TABLE 1.
Demographic, virologic, and biochemical characteristics of patients with acute HBV infectiona
| Patient | Age (yr) | Sex | 1st time point
|
2nd time point
|
3rd time point
|
Outcome | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wk from clinical presentation | AST/ALT | HBV DNA (copies/ml) | Wk from clinical presentation | HBV DNA (copies/ml) | AST/ALT | Wk from clinical presentation | HBV DNA (copies/ml) | AST/ALT | ||||
| 1B | 37 | M | 1 | 433/2,747 | 44,900 | 9 | <200 | 25/59 | 24 | <200 | 22/45 | Self-limited |
| 2B | 46 | M | 2 | 26/76 | <200 | 8 | <200 | 18/25 | 28 | <200b | 10/13 | Self-limited |
| 3B | 39 | M | 2 | 57/154 | 13,800 | 6 | 1,420 | 21/26 | 26 | <200 | 21/29 | Self-limited |
| 4B | 34 | M | 2 | 27/49 | <200 | 9 | <200 | 29/37 | 28 | <200 | 25/17 | Self-limited |
| 5B | 26 | M | 1 | 499/927 | <200 | 13 | <200 | 16/16 | ND | ND | ND | Self-limited |
Patients were studied at three different time points of the follow-up. ND, not determined; M, male. The lower limit of detection for HBV DNA is 200 copies/ml.
Viremia evaluated at a later time point relative to immunological analysis.